Structural Biology And Molecular Modeling Techniques Market Report 2026

Structural Biology And Molecular Modeling Techniques Market Overview

• Structural Biology And Molecular Modeling Techniques market size has reached to $10.28 billion in 2025 • Expected to grow to $23.53 billion in 2030 at a compound annual growth rate (CAGR) of 17.9% • Growth Driver: Rising Adoption Of Personalized Medicine To Drive Market Growth • Market Trend: Advancements In Generative AI Cloud Services Reshaping The Structural Biology And Molecular Modeling Techniques Market • North America was the largest region in 2025.

What Is Covered Under Structural Biology And Molecular Modeling Techniques Market?

Structural biology is the study of the three-dimensional structure of key molecules and macromolecules in biological systems, including sugars, proteins, and nucleic acids. Molecular modeling is the process of creating, visualizing, and modifying the three-dimensional structures of chemical and biological molecules and identifying physicochemical characteristics that can be used to interpret the structural activity relationship (SAR) of the biological molecules. The main types of tools used for structural biology and molecular modeling techniques are SaaS and standalone modeling, visualization and analysis, databases, and others. Software as a Service (SaaS) is a software distribution model in which a cloud provider hosts programs and makes them available to end users online. Standalone software is installed and maintained on the customer's computer, with the customer managing the program and hardware unless it is covered by the software maintenance and support offered by the Offeror. SaaS and standalone modelling are used for performing particular functions with a specified set of rules. The structural biology and molecular modeling techniques are applied in drug development, drug discovery, and other for pharmaceutical, biotechnological, academic, and clinical trial.

What Is The Structural Biology And Molecular Modeling Techniques Market Growth Forecast?

The structural biology and molecular modeling techniques market size is expected to see rapid growth in the next few years. It will grow to $23.53 billion in 2030 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increasing demand for accelerated drug development, rising adoption of cloud and saas modeling tools, expansion of precision medicine research, growing integration of ai in life sciences, increasing use of virtual screening platforms. Major trends in the forecast period include increasing adoption of ai-driven molecular modeling tools, rising use of cloud-based structural biology platforms, growing integration of simulation and docking software, expansion of data-driven drug discovery applications, enhanced focus on structure-based drug design.

Global Structural Biology And Molecular Modeling Techniques Market Segmentation

1) By Tools: SaaS And Standalone Modeling, Visualization And Analysis, Databases, Other Tools 2) By Application: Drug Development, Drug Discovery, Other Applications 3) By End-Users: Pharmaceutical, Biotechnological, Academic Subsegments: 1) By SaaS And Standalone Modeling: Cloud-Based Modeling Tools, Desktop Modeling Software 2) By Visualization And Analysis: Molecular Visualization Software, Structural Analysis Tools 3) By Databases: Protein Structure Databases, Molecular Interaction Databases 4) By Other Tools: Simulation Software, Docking Software, Other Analytical Tools

What Is The Driver Of The Structural Biology And Molecular Modeling Techniques Market?

The increasing adoption of personalized medicine is expected to propel the growth of the structural biology and molecular modeling techniques market going forward. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the individual characteristics of each patient. Structural biology and molecular modelling techniques play a crucial role in personalized medicine by enabling the identification and validation of molecular targets, supporting drug discovery and development, understanding genetic variations, predicting drug-target interactions, optimizing drug delivery, and contributing to biomarker discovery. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from 6 approvals in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the structural biology and molecular modelling techniques market.

Key Players In The Global Structural Biology And Molecular Modeling Techniques Market

Major companies operating in the structural biology and molecular modeling techniques market are Agile Molecule Inc., Dassault Systèmes SE, Chemical Computing Group ULC, Biomax Informatics AG, Acellera Ltd., Schrödinger Inc., OpenEye Scientific Software Inc., BioSolveIT GmbH, Optibrium Ltd., Simulations Plus Inc., Certara L.P., Genedata AG, Inte:Ligand GmbH, Molecular Networks GmbH, Molecular Discovery Ltd., Cresset Group Ltd., Biovista Inc., Collaborative Drug Discovery Inc., Dotmatics Ltd., Insilico Biotechnology AG, Leadscope Inc.

Global Structural Biology And Molecular Modeling Techniques Market Trends and Insights

Major companies operating in the structural biology and molecular modelling techniques market are developing new models such as AI cloud services to gain a competitive edge in the market. AI cloud services refer to the delivery of artificial intelligence capabilities and tools through cloud computing platforms, enabling businesses and developers to access, deploy, and scale AI applications without the need for extensive on-premises infrastructure. For instance, in March 2023, Nvidia Corporation, a US-based software company, launched a set of generative AI cloud services under the BioNeMo Cloud offering, part of NVIDIA AI Foundations. This service accelerates life sciences research, drug discovery, and protein engineering by providing pretrained AI models and allowing researchers to customize them with proprietary data. The service includes six new optimized, open-source models, such as AlphaFold2 for protein structure determination and MoFlow for molecular optimization and small molecule generation.

What Are Latest Mergers And Acquisitions In The Structural Biology And Molecular Modeling Techniques Market?

In August 2023, Optibrium, a UK-based developer of software and AI solutions for drug discovery, acquired BioPharmics LLC for an undisclosed amount. Through this acquisition, Optibrium aims to expand its 3D drug design and visualization capabilities, integrating advanced ligand- and structure-based modeling into its StarDrop platform for small molecule design, optimization, and data analysis. BioPharmics LLC is a US-based computational drug design company providing industry-leading algorithms and software for 3D ligand conversion, conformer generation, molecular docking, molecular similarity analysis, and binding affinity prediction.

Regional Outlook

North America was the largest region in the structural biology and molecular modelling techniques market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Structural Biology And Molecular Modeling Techniques Market?

The structural biology and molecular modeling techniques market includes revenues earned by entities by using techniques such as homology modeling, threading, molecular dynamics cryo-electron microscopy (cryo-EM), nuclear magnetic resonance spectroscopy of proteins (NMR), and electron paramagnetic resonance (EPR). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.